Posted by Clinical Lab Products | Jan 27, 2009 | Miscellaneous |
CombiMatrix Corporation announces that its wholly owned subsidiary, Combimatrix Molecular Diagnostics, has entered into a new partnership with Lenetix, a New York based laboratory, to co-market CMDXs suite of array CGH based tests.
Read MorePosted by Clinical Lab Products | Jan 21, 2009 | Miscellaneous |
New analyses show that genetic testing used to guide initial dosing of the blood-thinner warfarin may not be cost-effective for typical patients with atrial fibrillation but may be for patients at higher risk for major bleeding.
Read MorePosted by Clinical Lab Products | Jan 5, 2009 | Cancer, Miscellaneous |
DxS Ltd has expanded its license with Genzyme Genetics, a business unit of Genzyme Corporation, for epidermal growth factor receptor (EGFR) to include the United States and Canada.
Read MorePosted by Clinical Lab Products | Dec 30, 2008 | Sexually Transmitted Diseases |
The U.S. Food and Drug Administration approved the cobas TaqScreen MPX Test, the first nucleic acid test that screens for the presence of two divergent types of HIV in donated blood plasma and tissue.
Read MorePosted by Clinical Lab Products | Dec 17, 2008 | Cancer, Miscellaneous |
CombiMatrix Corporation has announced the introduction of the ProScan, which complements the company’s growing portfolio of array-based diagnostic tests.
Read More